KMB heads into Q4 earnings with expected revenue and EPS declines, pressured by promotions, tariffs and FX, even as core demand and productivity hold up.

We came across a bullish thesis on Kimberly-Clark Corporation on Value investing subreddit by Exciting_Elephant351. In this ...

Looking ahead, Kimberly-Clark ( KMB) said it expects 2026 organic sales growth to grow in line with or ahead of the weighted ...

Kimberly‑Clark Corporation (NASDAQ:KMB) is one of the best trade‑war resistant stocks to buy now. On July 25, 2025, JPMorgan analyst Andrea Teixeira maintained her Underweight rating on KMB while ...

All right. Well, thanks, everyone, for coming. It's -- welcome to, this is Piper's Fourth Annual Growth Frontiers Conference. It's our pleasure today to have Kimberly-Clark here with us. We've got ...

Globally operating Kimberly-Clark Corporation (NASDAQ: KMB) delivered strong earnings and expressed confidence in its progress.

We recently published 10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive. Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently discussed. Kimberly-Clark ...

Walk into any store, a bottle of Tylenol will cost you a few bucks. We also know the price tag for the company that makes Tylenol - almost $49 billion. Consumer products giant Kimberly-Clark said ...

Kimberly-Clark, is acquiring Tylenol's parent company Kenvue in a cash and stock deal worth nearly 50 billion, creating a massive consumer health products company. The Kimberly-Clark conglomerate, ...

DALLAS, April 2, 2025 /CSRwire/ – Kimberly-Clark has received the 2025 World’s Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical ...